Wickremsinhe ER - Search Results

1

Quantification of abemaciclib and metabolites: evolution of bioanalytical methods supporting a novel oncolytic agent.

Wickremsinhe ER, Lee LB. Wickremsinhe ER, et al. Bioanalysis. 2021 May;13(9):711-724. doi: 10.4155/bio-2021-0039. Epub 2021 Apr 19. Bioanalysis. 2021. PMID: 33870730 Free article.

2

Dried blood spot sampling: coupling bioanalytical feasibility, blood-plasma partitioning and transferability to in vivo preclinical studies.

Wickremsinhe ER, Abdul BG, Huang NH, Richard JW, Hanes JL, Ruterbories KJ, Perkins EJ, Chaudhary AK. Wickremsinhe ER, et al. Bioanalysis. 2011 Jul;3(14):1635-46. doi: 10.4155/bio.11.124. Bioanalysis. 2011. PMID: 21756096

3

Preclinical bridging studies: understanding dried blood spot and plasma exposure profiles.

Wickremsinhe ER, Huang NH, Abdul BG, Knotts K, Ruterbories KJ, Manro JR. Wickremsinhe ER, et al. Bioanalysis. 2013 Jan;5(2):159-70. doi: 10.4155/bio.12.309. Bioanalysis. 2013. PMID: 23330559

4

High sensitive assay employing column switching chromatography to enable simultaneous quantification of an amide prodrug of gemcitabine (LY2334737), gemcitabine, and its metabolite dFdU in human plasma by LC-MS/MS.

Wickremsinhe ER, Lee LB, Schmalz CA, Torchia J, Ruterbories KJ. Wickremsinhe ER, et al. J Chromatogr B Analyt Technol Biomed Life Sci. 2013 Aug 1;932:117-22. doi: 10.1016/j.jchromb.2013.06.008. Epub 2013 Jun 13. J Chromatogr B Analyt Technol Biomed Life Sci. 2013. PMID: 23831704

5

2015 White Paper on recent issues in bioanalysis: focus on new technologies and biomarkers (Part 1 - small molecules by LCMS).

Welink J, Fluhler E, Hughes N, Arnold M, Garofolo F, Bustard M, Coppola L, Dhodda R, Evans C, Gleason C, Haidar S, Hayes R, Heinig K, Katori N, Blaye OL, Li W, Liu G, Lima Santos GM, Meng M, Nicholson B, Savoie N, Skelly M, Sojo L, Tampal N, de Merbel Nv, Verhaeghe T, Vinter S, Wickremsinhe E, Whale E, Wilson A, Witte B, Woolf E. Welink J, et al. Bioanalysis. 2015;7(22):2913-25. doi: 10.4155/bio.15.204. Epub 2015 Nov 17. Bioanalysis. 2015. PMID: 26573485 Free article.

6

Incorporating dried blood spot LC-MS/MS analysis for clinical development of a novel oncolytic agent.

Wickremsinhe ER, Callies S, Schmalz CA, Lee LB, LaBell ES, Satonin DK. Wickremsinhe ER, et al. Bioanalysis. 2018 Mar 1;10(5):341-356. doi: 10.4155/bio-2017-0231. Epub 2018 Feb 16. Bioanalysis. 2018. PMID: 29451018

7

A decade of incurred sample reanalysis: failures, investigations and impact.

Lee LB, Wickremsinhe ER. Lee LB, et al. Among authors: wickremsinhe er. Bioanalysis. 2018 Nov 1;10(21):1767-1772. doi: 10.4155/bio-2018-0214. Epub 2018 Oct 10. Bioanalysis. 2018. PMID: 30301360

8

Microsampling for quantitative bioanalysis, an industry update: output from an AAPS/EBF survey.

Patel SR, Bryan P, Spooner N, Timmerman P, Wickremsinhe E. Patel SR, et al. Bioanalysis. 2019 Apr;11(7):619-628. doi: 10.4155/bio-2019-0019. Epub 2019 Apr 11. Bioanalysis. 2019. PMID: 30973016 Free article.

9

Microsampling: considerations for its use in pharmaceutical drug discovery and development.

Spooner N, Anderson KD, Siple J, Wickremsinhe ER, Xu Y, Lee M. Spooner N, et al. Among authors: wickremsinhe er. Bioanalysis. 2019 May;11(10):1015-1038. doi: 10.4155/bio-2019-0041. Bioanalysis. 2019. PMID: 31218897 Review.

10

Evaluation of correlation between bioanalytical methods.

Gleason CR, Ji QC, Wickremsinhe ER. Gleason CR, et al. Among authors: wickremsinhe er. Bioanalysis. 2020 Mar;12(6):419-426. doi: 10.4155/bio-2020-0019. Epub 2020 Apr 14. Bioanalysis. 2020. PMID: 32285680

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

43 results

Search Page